Peter MacCallum Cancer Centre

Research facility


Location: Melbourne, Australia (AU) AU

ISNI: 0000000403978434

ROR: https://ror.org/02a8bt934

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study (2018) Rambau PF, Vierkant RA, Intermaggio MP, Kelemen LE, Goodman MT, Herpel E, Pharoah PD, et al. Journal article Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility (2018) Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, et al. Journal article Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE) (2017) Loibl S, De La Pena L, Nekljudova V, Zardavas D, Michiels S, Denkert C, Rezai M, et al. Journal article Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci (2017) Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann M, et al. Journal article Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer (2017) Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, et al. Journal article Assessing the genetic architecture of epithelial ovarian cancer histological subtypes (2016) Cuellar-Partida G, Lu Y, Dixon SC, Fasching PA, Hein A, Burghaus S, Beckmann M, et al. Journal article Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study (2016) Ong JS, Cuellar-Partida G, Lu Y, Fasching PA, Hein A, Burghaus S, Beckmann M, et al. Journal article Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group (2016) Denkert C, Wienert S, Poterie A, Loibl S, Budczies J, Badve S, Bago-Horvath Z, et al. Journal article No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing (2016) Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, et al. Journal article Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration (2016) Permuth JB, Reid B, Earp M, Chen YA, Monteiro ANA, Chen Z, Chenevix-Trench G, et al. Journal article
1 ... 4 5 6 7 8